The United States biobanks market
is expected to grow at a significant rate during the forecast period. Growing
need to store and preserve the biological samples such as nucleic acids,
tissues, blood which are in demand for research activities for advancements in
biomedical research and identify disease-relevant biomarkers. The rise in the
number of research activities is considered the major driver for the forecast
period. An increase in investments and funding made by the leading authorities
and market players to advance the sectors such as regenerative medicine, cell
& gene therapy, stem cell therapeutics is promoting the scope of research
activities which in turn is accelerating the market growth. The surge in the
adoption of cord blood banking techniques by healthcare facilities offers
several benefits, such as more people can receive stem cells than received
through the bone marrow, and this process is less complicated and painful for
the donor, which in turn is fostering the growth of the biobanks market.
Biobanks play a significant role in maintaining and updating the age
demographic databases. The rising demand for personalized medicine as it is
considered more effective and provides better results is contributing to the
surge in the biobanks market growth.
United States biobanks market is
segmented into type, ownership, product, specimen type, application, end-user,
regional distribution, and company. Based on product, the market can be divided
into equipment & consumables, media, software & services. The equipment
& consumables product segment is expected to hold a major market share in
the forecast period. The rise in the number of biobanks is aiding to increase
the capacity to store a large number of bio-samples is increasing the demand
for biobanking devices which in turn is accelerating the market growth.
The major players operating in the
United States biobanks market are Thermo Fisher Scientific Inc., Hamilton
Company, Brooks Automation, Inc., VWR Corporation, LLC, Promega Corporation,
Becton, Dickinson, and Company, RUCDR Infinite Biologics, LabVantage Solutions
Inc., US Biolab Corporation, Inc., ProteoGenex, Inc., Cureline, Inc., Bay
Biosciences LLC, Geneticist Inc, BioLifeSolutions Inc., among others. Major
companies are developing advanced technologies and launching new services to
stay competitive in the market. Other competitive strategies include mergers
& acquisitions and new service developments.
Objective of the Study:
- To analyze the historical growth of the market
size of United States biobanks market from 2017 to 2020.
- To estimate and forecast the market size of United
States biobanks market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States biobanks
market based on type, ownership, product, specimen type, application, end
user, regional distribution, and company.
- To identify dominant region or segment in the United
States biobanks.
- To identify drivers and challenges for United
States biobanks market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in United
States biobanks market.
- To identify and analyze the profile of leading
players operating in United States biobanks market.
- To identify key sustainable strategies adopted
by market players in United States biobanks market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of service providers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the service providers who
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the service providers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of United States biobanks market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Biobank service provider
companies
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums, and
alliances related to biobanks market.
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as service providers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
|
Attribute
|
Details
|
|
Base Year
|
2021
|
|
Historic Data
|
2017 – 2020
|
|
Estimated Year
|
2022
|
|
Forecast Period
|
2023 – 2027
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
·
Type
·
Ownership
·
Product
·
Specimen Type
·
Application
·
End User
|
|
Regional scope
|
South-West, Mid-West, North-East
|
|
Key companies profiled
|
Thermo Fisher Scientific Inc., Hamilton
Company, Brooks Automation, Inc., VWR Corporation, LLC, Promega Corporation,
Becton, Dickinson, and Company, RUCDR Infinite Biologics, LabVantage
Solutions Inc., US Biolab Corporation, Inc., ProteoGenex, Inc., Cureline,
Inc., Bay Biosciences LLC, Geneticist Inc, BioLifeSolutions Inc.
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, United States biobanks
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
United States Biobanks Market, By Type:
- Population Based Biobanks
- Disease Oriented Biobanks
- United States Biobanks Market, By Ownership:
- National/regional agency
- Non-profit Organization
- Universities
- Private Organization
- United States Biobanks Market, By Product:
- Equipment
& Consumables
- Media
- Software
& Services
- United States Biobanks Market, By Specimen Type:
- Blood Products
- Solid Tissue
- Cell Lines
- Nucleic Acid
- Others
- United States Biobanks Market, By Application:
- United States Biobanks Market, By End User:
- Academic
Institutes
- Pharma
& Biotech Companies
- Others
- United States Biobanks Market, By Region:
- South
- West
- Mid-West
- North East
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in United States biobanks market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
United States biobanks market is an upcoming report to be released soon.
If you wish an early delivery of this report or want to confirm the date of
release, please contact us at [email protected]